Holdings of the Fund as of 6/9/2025
Total Number of Holdings (excluding cash): 30
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Health Care |
2,184,722 |
$48,719,300.60 |
4.66% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Health Care |
350,537 |
$44,073,017.01 |
4.22% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Health Care |
133,967 |
$40,725,968.00 |
3.90% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Health Care |
716,609 |
$39,148,349.67 |
3.74% |
| Incyte Corporation |
INCY |
45337C102 |
Health Care |
560,107 |
$39,145,878.23 |
3.74% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Health Care |
902,102 |
$38,718,217.84 |
3.70% |
| Genmab A/S (ADR) |
GMAB |
372303206 |
Health Care |
1,693,421 |
$37,678,617.25 |
3.60% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Health Care |
113,292 |
$37,205,092.80 |
3.56% |
| Biogen Inc. |
BIIB |
09062X103 |
Health Care |
276,576 |
$37,102,670.40 |
3.55% |
| Alkermes Plc |
ALKS |
G01767105 |
Health Care |
1,179,750 |
$36,737,415.00 |
3.51% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
Health Care |
30,572 |
$36,545,463.08 |
3.50% |
| BeOne Medicines Ltd. (ADR) |
ONC |
07725L102 |
Health Care |
138,276 |
$36,474,443.28 |
3.49% |
| Illumina, Inc. |
ILMN |
452327109 |
Health Care |
425,959 |
$36,197,995.82 |
3.46% |
| BioNTech SE (ADR) |
BNTX |
09075V102 |
Health Care |
330,017 |
$35,961,952.49 |
3.44% |
| Natera, Inc. |
NTRA |
632307104 |
Health Care |
215,166 |
$35,328,105.54 |
3.38% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Health Care |
307,375 |
$34,733,375.00 |
3.32% |
| Moderna, Inc. |
MRNA |
60770K107 |
Health Care |
1,215,773 |
$34,211,852.22 |
3.27% |
| Repligen Corporation |
RGEN |
759916109 |
Health Care |
259,264 |
$34,139,883.52 |
3.27% |
| Waters Corporation |
WAT |
941848103 |
Health Care |
97,944 |
$34,116,833.52 |
3.26% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Health Care |
464,198 |
$32,758,452.86 |
3.13% |
| Amgen Inc. |
AMGN |
031162100 |
Health Care |
111,383 |
$32,298,842.34 |
3.09% |
| Bruker Corporation |
BRKR |
116794108 |
Health Care |
821,808 |
$32,223,091.68 |
3.08% |
| argenx SE (ADR) |
ARGX |
04016X101 |
Health Care |
54,831 |
$32,000,468.22 |
3.06% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Health Care |
560,599 |
$31,886,871.12 |
3.05% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Health Care |
57,478 |
$29,750,612.80 |
2.85% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Health Care |
65,783 |
$29,349,085.45 |
2.81% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Health Care |
529,018 |
$28,767,998.84 |
2.75% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Health Care |
1,001,674 |
$27,896,620.90 |
2.67% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Health Care |
193,050 |
$26,270,244.00 |
2.51% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Health Care |
624,206 |
$24,787,220.26 |
2.37% |
| US Dollar |
$USD |
|
Other |
641,748 |
$641,748.23 |
0.06% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|